KELIM score and BRCA status are unreliable to predict the completeness of cytoreduction during interval debulking surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancers
After the maturation of the HIPEC techniques, this procedure is safe and feasible. Currently, there are no reliable pre-operative markers, including KELIM score or BRCA1/2 status, which could predict the CC score after surgery.
Authors
- Hsiao-Li Kuo
- Jian-Syun Chen (ORCID: https://orcid.org/0000-0002-0606-5927)
- Kung‐Liahng Wang (ORCID: https://orcid.org/0000-0002-9439-0622)
- Tzu-Chien Chen
- Jen‐Ruei Chen (ORCID: https://orcid.org/0000-0001-8475-8705)
- Fan Yin (ORCID: https://orcid.org/0000-0001-5460-1117)
Institutions
- Taipei Medical University Hospital (TW)
- Mackay Memorial Hospital (TW)
Publication Details
- Journal
- Taiwanese Journal of Obstetrics and Gynecology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.tjog.2025.05.015
- Citations
- 5
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 10.03